VIVUS, Inc (VVUS) Covered Calls

VIVUS, Inc covered calls VIVUS, Inc. is engaged in the development and commercialization of therapeutic products for large underserved markets.

You can sell covered calls on VIVUS, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VVUS (prices last updated Thu 1:25 PM ET):

VIVUS, Inc (VVUS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.59 -0.03 3.56 3.60 19K -1.0 0.0B
Covered Calls For VIVUS, Inc (VVUS)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 4 0.14 3.46 4.0% 63.5%
Jun 21 4 0.33 3.27 10.1% 63.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.